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Abstract
Background: Juvenile idiopathic arthritis (JIA) is a rare disease that is not widely known by paediatricians and
general practitioner (GP) leading to diagnostic error and delayed care provision. We aimed to analyse patient’s
journey and time to diagnosis of JIA (delay from the first symptom to the diagnosis of JIA).
We performed a retrospective cohort study of 67 patients diagnosed with JIA and seen in the paediatric rheumatology
department of the Kremlin Bicêtre Hospital, between July 2002 and January 2015. Patients were selected for
analysis in order to represent an equal distribution of five JIA subtypes: oligoarticular onset (21), polyarticular
onset (13), enthesitis-related arthritis (17), and systemic onset (16).
Results: Sixty-seven patients were finally analysed (42 girls). Before JIA diagnosis was made, patients had visited a
mean of three physicians (3.6 ± 1.4 (mean; SD)). Emergency room physicians (52%) were the first patient’s referral
before GP (42%). Paediatric rheumatologists were mostly seen as third referral (52% versus 3% at first referral).
Reactive arthritis (34%) and septic arthritis (24%) represented both the most common initial diagnosis. JIA was suspected
after an average median time delay of 3 months (0.26–81.2) except for 25 patients (37%): SJIA (n = 9), ERA (n = 7), OAJIA
(3) and POJIA (n = 6) for whom diagnosis was suspected straightaway. In most cases (88%), JIA was established by
paediatric rheumatologists.
Surprisingly, the median total time to diagnosis in our population was rather short (3 months). Paediatric rheumatologist
played a major role in making the diagnosis but the journey to reach them was long and complex with multiple referrals.
These results reinforce the necessity of improving GP and emergency physician’s awareness and education on paediatric
rheumatic diseases as the importance of a strong network in paediatric rheumatology to improve patient’s level of care.
Conclusion: We highlighted the complex patient’s journey to diagnosis in children with JIA and made assumptions that
reference center might reduce time to diagnosis although not statically proven. Further analysis with a larger number of
patients might be needed to better investigate this probability.
Keywords: Juvenile arthritis, Health surveys, Arthritis, Juvenile/diagnosis*, Retrospective studies, Rheumatology, Referral
and consultation/statistics & numerical data*, Pediatrics
Background
Juvenile idiopathic arthritis, JIA, is the most frequent
cause of inflammatory arthritis in children before 16 years.
Even if considered a rare disease, it’s estimated incidence
rate is different around the world with low incidence in
Asian population and relatively higher incidence in those
of European descent (0.83 per 100,000 children in Japan
to 23 per 100,000 in Norway per year) [1, 2]. Only few
surveys have assessed epidemiology of JIA in France
but nothing is known on patient’s journey to accurate
diagnosis and care. JIA is currently classified into seven
subtypes according to the Edmonton consensus meeting
2001 [3]. Even if paediatric rheumatology is still considered
a young subspecialty in many countries, the standards of
medical education and patient’s care have considerably
evolved with time [4]. In contrast to that, the academic rec-
ognition of this subspecialty and the opportunities to get
appropriate medical education remain clearly insufficient
in many European countries. Indeed, until the early years
2000, the whole paediatric rheumatology expertise repre-
sented a maximum of five centres in France. At the same
time, in other European countries and in the United states,
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the evolution of concepts and the use of biological
treatments had considerably modified the patient’s care
toward highly specialized multidisciplinary paediatric
rheumatology teams [5, 6]. In 2004, the French health
minister initiated a national campaign for rare diseases
that has dramatically changed the recognition of paediatric
rheumatology. Indeed, this campaign lead to the labelling
of two reference centres in 2006 and 2007 with a network
of 18 competence centres throughout the national territory
[7]. We can hypothesise that this new organization has
increased the quality of care for patients with rheumatic
diseases, with a growing number of opportunities for
young paediatricians to access accurate medical education
in paediatric rheumatology. Despite this new organisation,
paediatricians and general practitioner (GP) have insufficient
knowledge regarding rheumatic diseases and paediatric
musculoskeletal clinical examination [8] probably leading
to an underestimation of the actual number of JIA patients
in France. As joint symptoms are the most common initial
complaints at disease onset, we hypothesized that the lack
of knowledge underlies diagnostic error - a great source of
suffering for patients and their families - and delayed care
provision. To better assess the remaining unmet needs in
our country, we aimed to analyse patient’s journey and time
to diagnosis of JIA.
Methods
We performed a retrospective cohort study of patients
diagnosed with JIA according to the ILAR criteria and
seen in the paediatric rheumatology center of Kremlin
Bicêtre, a single tertiary and reference center for paediatric
rheumatology in France, between July 2002 and January
2015. Patients were randomly selected for analysis and
classified in five JIA subtypes: e.g. oligoarticular onset
(OAJIA), oligo-onset (persistent and extended) polyar-
ticular onset (POJIA) (rheumatoid factor (RF) positive
and negative), enthesitis-related arthritis (ERA), and
systemic onset (SoJIA). In addition, sufficient informa-
tion on patient’s journey to diagnosis and care was
required.
We collected demographic clinical and biological
information (C-reactive protein level, erythrocyte sedi-
mentation rate, antinuclear antibodies (ANA), RF and
HLA-B27) where available. We recorded also all major
medical investigations and referrals, treatments and
differential diagnoses made before diagnosis confirm-
ation. The time to diagnosis was defined as the delay
from the first symptom to the diagnosis of JIA. Ac-
cording to our national regulations, no IRB approval
was required.
The cohort’s characteristics, time to diagnosis, and
other variables were analysed using descriptive statis-
tics. Total time to diagnosis was secondarily adjusted
on sex, age and number of symptoms at disease onset,
type of JIA, first referral physician consulted and the




Sixty-seven patients were finally analysed (25 boys; M/F SR:
0.6): 21 were diagnosed with OAJIA, 16 with SoJIA, 17 with
ERA and 13 with POJIA. Mean age at disease onset was of
6.4 ± 4.6 years (mean; SD) (0.5–15.6). The whole population
characteristics are summarized in Table 1.
The most common symptoms that led to seek medical
attention at disease onset, were arthralgia (39%), arthritis
(25%), and fever (18%) followed by skin rash (8%), limping
(9%), abdominal pain (1.3%), and uveitis (1.3%). Before JIA
diagnosis was made, patients had visited a mean of three
physicians (3.6 ± 1.4 (mean; SD)). Emergency room physi-
cians (52%) were the first patient’s referral before the
general practitioner (42%) (Fig. 1). Reactive arthritis (34%)
and septic arthritis (24%) represented both the most com-
mon initial diagnosis. Fifty-two patients (78%) underwent
radiological exams, in which X-rays (49%) and articular
ultrasounds (36%). Twelve patients (17%) had joint fluid
aspiration. Nineteen patients (28%) received antibiotics;
mostly amoxicillin plus clavulanic acid (13.4%). JIA was
suspected after an average median time delay of 3 months
(0.26–81.2) except for 25 patients (37%): SJIA (n = 9), ERA
(n = 7), OAJIA (3) and POJIA (n = 6) for whom diagnosis
was suspected straightaway (Fig. 2). In most cases (88%),
JIA was established by paediatric rheumatologists.
Systemic onset JIA
Sixteen patients had SoJIA (9 boys; M/F SR: 1.28). Age
at disease onset was of 6.4 ± 2.5 years (mean; SD) (0.4–
15.2) and initial symptoms included fever 81%, skin rash
37.5%, and arthralgia 31% (Fig. 3). At first referral, the
most frequently consulted physicians were GP’s (56%) and
emergency department physicians (37%) with a mean of
1.6 hospitalizations. SoJIA was diagnosed out of hand in
43.7% of cases. Different diagnoses were discussed before
JIA was diagnosed such as: reactive arthritis (31%), septic
arthritis (12.5%) and osteomyelitis (12.5%). X-rays were
performed in half cases, joint ultrasounds in 31% of cases
and bone scintigraphy in 25% of cases. Fifty-six per cent of
patients received antibiotics. Paediatric rheumatologists
made the diagnosis of SoJIA in 87.5% of cases and within
a median period of 1.3 months (0.3–9).
Oligoarthritis onset JIA
Twenty-one patients (6 boys; M/F SR: 0.4) started their
disease at 3.6 ± 2.9 years (mean; SD) (1.08-11.6). Arthritis
(62%) and arthralgia (24%) were the main presenting
symptoms (Fig. 3). Emergency physicians (71%) were the
most consulted at first referral and patients had a mean of
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0.7 hospitalizations. Septic arthritis (52%) and reactive
arthritis (43%) were initially diagnosed although no
patients presented with fever. JIA was initially suspected
in three patients (14%). X-rays were performed in 67%
and joint ultrasound in 57%. Patients had received antibi-
otics in 38% of cases even in patients without evidence of
bacterial infection at joint aspiration fluid analysis (38%).
OAJIA patients were the most investigated due to mono-
articular presentation (57% of monoarthritis) at disease
onset. Orthopaedics cares (25%) were therefore provided
leading to hospitalisation (67%), arthrocentesis (38%) per-
formed, in most cases, under general anaesthetic due to
age, arthrotomy (5%) and arthroscopic synovectomy (5%).
JIA diagnosis was made by paediatric rheumatologist in
76% of cases with a median delay of 3 months (0.5–28).
Polyarthritis onset JIA
Thirteen patients (5 boys; M/F SR: 0.6), started their
disease at 5.7 ± 4.2 years (mean; SD) (0.9–13). Arthralgia
(77%) and arthritis (15.4%) were the main presenting
symptoms (Fig. 3). JIA was suspected at first referral to a
physician in most cases (46%). GP and emergency physi-
cians were the first consulted physicians with a mean of
0.7 hospitalisations. X-rays were performed in 54% of
cases and joint ultrasound in 15% of cases. In some cases,
(31%), patients had received prior antibiotics. Paediatric
rheumatologist made the diagnosis in 92% of cases, within
a median delay of 2.5 months (0.5–81.2).
ERA onset JIA
Seventeen patients (9 boys; M/F SR: 1.1) started their
disease at 10.4 ± 4.2 years (mean; SD) (1.5–15.6). Initial
symptoms were mostly arthralgia (59%), arthritis (17.6%)
and limping (17,6%) (Fig. 3). Septic and reactive arthritis
were the two most frequent initially suspected diagnoses.
Among reactive arthritis, 23.5% of patients were first diag-
nosed with transient hip synovitis. As in other JIA sub-
groups, emergency physicians (53%) and GP (35%) were
the first referrals. JIA ERA patients had more radiological
exams (82%), such as MRI (41%) and joint ultrasound
(29%). Unlike in other JIA subtype, JIA ERA patients were
exclusively diagnosed by paediatric rheumatologist within
a median delay of 5.5 months (1–29) after a mean of 0,6
hospitalisations.
Discussion
This study analyses a representative cohort of JIA patients
affected by four main JIA subtypes [9]. Surprisingly, the
median total time to diagnosis in our population was rather
short (3 months) considering that JIA is characterized by
arthritis persisting for more than six weeks. No factors in-
fluencing diagnosis delay were shown in multivariate ana-
lysis probably due to a too small population. Children with
systemic-onset JIA had the shortest delay to diagnosis.
Indeed, i.e. prolonged fever associated to intense consti-
tutional symptoms, generally lead to hospitalization and
accelerated paediatric rheumatology referral. As expected,
Table 1 Population characteristics
Sex (F/M) Age at disease onset
(years; mean ± SD)
Min-Max (years) ANA+ RF+ HLAB27
Oligoarticular JIA 15/6 3,6 ± 2,9 1–11,6 38% 0% 12%
Polyarticular JIA 12/1 5,7 ± 4,2 0,9–13 54% 10% 0%
ERA JIA 8/9 10,3 ± 4,2 1,5–15,6 18% 0% 44%
Sytemic JIA 7/9 6,4 ± 4,3 0,4–15 25% 0% 0%
Total 42/25 6,4 ± 4,6 0,5–15,6 42% 10% 33%
JIA juvenile idiopathic arthritis, F female, M male, JIA juvenile idiopathic arthritis, ANA Antinuclear antibody, RF Rheumatoid factor
Fig. 1 Graph representing the different physicians seen at first, second and third referral
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total time to diagnosis of ERA was the longest and paedi-
atric rheumatologists made the diagnosis in all cases. In-
deed, making a relationship between back pain and
possible inflammatory arthritis as well as recognizing
enthesitis requires appropriate specialized referral. In
Weiss and al. study, 66% of JIA patients had tender
entheses with a median number of 2 tender entheses at
initial evaluation. Enthesitis were more often symmetrical
and affected mostly the patellar ligament insertion, the plan-
tar fascial insertion at the calcaneus, the Achilles tendon
insertion at the calcaneus and the plantar fascial insertion at
the metatarsal heads [10]. In addition, GP or general
paediatrician almost always consider inflammatory hip
pain in children as transient synovitis, even though this
diagnosis should remain of exclusion and limited to
younger patients (mean 5.6 years old; rage: 1–13) [11].
In Rostom’s study, hip arthritis was described in 40 out
of 121 JIA patients (33%) especially in ERA and polyar-
ticular JIA. Hip pain appeared at an average age of 24 ±
10 years (3–46 years) in Rostom and al.’s study [12] and
at a mean age of 10 ± 4 years in our JIA cohort.
Paediatric rheumatologist played a major role in making
the diagnosis but the journey to reach them was long
(6 months on average) and complex with multiple referrals
(99%), unjustified diagnostic procedures and inappropriate
diagnoses [13, 14]. Similar observations were reported by
Feder and al. [13]. In the absence of trauma or sepsis, JIA is
the most likely diagnosis in a child presenting with a mono-
arthritis, and arthroscopy and synovial biopsy are rarely
warranted [13]. Imaging such as computerized tomography
and isotope bone scans incur considerable radiation expos-
ure; magnetic resonance imaging and ultrasound are often
used but the diagnosis of JIA can usually be made without
these tests. In addition to multiple investigations, pa-
tient received multiple courses of medication namely
antibiotics. Diagnostic criteria for septic arthritis (SA)
should be strictly abided by clinical and biological features
such as: weight-bearing status, CRP >20 mg/L [15] and joint
aspiration bacteriological results, to minimize needless anti-
biotic. In our study, all patients with joint aspiration were
treated with antibiotics for a period of 4 to 6 weeks although
no sign of infection were found. This attitude is unfortunate
knowing how the misuse of antibiotic can be damaging.
Some studies suggest that environmental factors impacting
the composition of the microbiota, such as delivery mode
and early exposure to antibiotics, affect the risk of chronic
inflammatory diseases including JIA [16, 17]. For all these
reasons, our study reinforces the necessity of improving GP
and emergency physician’s awareness and education on
paediatric rheumatic diseases [8, 18]. In addition, the com-
plexity of JIA patient’s journey to accurate diagnosis and
care allows us to highlight the importance of a strong net-
work in paediatric rheumatology to improve patient’s level
of care. At the European level, strong networks have been
created in the past few years in order to support recommen-
dations of care, research and patient’s education of paediatric
Fig. 2 Histogram showing time to diagnosis (months) according to each juvenile idiopathic arthritis (JIA) subgroups. Median time to diagnosis
are given for each JIA subtypes (months)
Fig. 3 Graph showing the presenting symptoms at disease onset for
each juvenile idiopathic arthritis (JIA) subtypes
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rheumatology: Paediatric Rheumatology European Society
(PRES), Paediatric Rheumatology International Trials
Organisation (PRINTO) together with the EULAR Stand-
ing Committee on Paediatric Rheumatology [4, 5].
Our study represents a first attempt to determine the
level of wandering in JIA diagnosis in a country which
has been the first to increase the visibility of care for
rare diseases by creating reference centres. Although the
distance between home and the reference center was not
found to correlate with time to diagnosis, we made as-
sumptions that it could be one reason for rather earlier
referral than previously reported in other Western coun-
tries; indeed, three-fourths of patients referred to us for
JIA are living in Paris and the “Ile de France” region. An
analysis with larger number of patients might be needed
to better investigate this probability. Nevertheless, other
factors could play a key role in reducing time to diagnosis
such as elevated ESR, type of JIA and presence of enthesitis.
Larger studies are needed to evaluate these parameters.
However, the apparent limited median delay to diagnosis
observed herein must be dampened by the wide ranges, up
to 86 months in POJIA. In addition, part of the collection
of data was retrospective including somewhat recall biases.
Conclusion
In conclusion, we have highlighted the complex patient’s
journey to diagnosis in JIA, possibly improved by our
reference center effect although no significant correlation
was found. The limited number of patients presented calls
for a nationwide survey.
Abbreviations
ANA: Antinuclear antibodies; ERA: Enthesitis-related arthritis; GP: General
practitioner; JIA: Juvenile idiopathic arthritis; OAJIA: Oligoarticular onset
Juvenile idiopathic arthritis; POJIA: Polyarticular onset Juvenile idiopathic
arthritis; PRES: Paediatric Rheumatology European Society; PRINTO: Paediatric
Rheumatology International Trials Organisation; RF: Rheumatoid factor;





Availability of data and materials
Data and materiel were taken from the pediatric rheumatological department
archive of Kremlin Bicêtre hospital.
Authors’ contributions
LA: data acquisition and interpretation, writing and analysis, LRS: revising the
article and discussion, data interpretation, IKP: revising the article and
discussion, data interpretation, PD: conception, design, writing, analysis and
interpretation of data. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
No IRB approval was required.
Author details
1Division of Pediatric Rheumatology, Bicêtre Hospital, APHP, University of
Paris SUD, 78 rue du Général Leclerc, Le Kremlin-Bicêtre, Cedex 94270,
France. 2Reference Center for Auto-inflammatory Disorders CEREMAI, Paris,
France.
Received: 13 August 2016 Accepted: 4 February 2017
References
1. Berntson L, Andersson Gäre B, Fasth A, Herlin T, Kristinsson J, Lahdenne P,
et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A
population based study with special reference to the validity of the ILAR
and EULAR criteria. J Rheumatol. 2003;30:2275–82.
2. Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile
idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81:112–7.
3. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al.
International League of Associations for Rheumatology classification of
juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol.
2004;31:390–2.
4. Gäre BA. EULAR standing committee on paediatric rheumatology. Ann Rheum
Dis. 2001;60:1014–5.
5. Ruperto N, Martini A. Networking in paediatrics: the example of the Paediatric
Rheumatology International Trials Organisation (PRINTO). Arch Dis Child. 2011;
96:596–601.
6. Spencer CH. Why should pediatric rheumatology be recognized as a
separate subspecialty: an open letter to medical councils and government
agencies. Pediatr Rheumatol Online J. 2007;5:21.
7. Les Cahiers d'Orphanet - Maladies Rares Info. Serviceswww.maladiesraresinfo.
org/…/pdf/Liste_des_centres_de_reference_labellises_maladie…2. oct. 2010-
http://www.orpha.net/orphacom/cahiers/docs/FR/Liste_des_centres_de_
reference_labellises_maladies.pdf. série Politique de santé. 2.
8. Myers A, McDonagh JE, Gupta K, Hull R, Barker D, Kay LJ, et al. More “cries
from the joints”: assessment of the musculoskeletal system is poorly
documented in routine paediatric clerking. Rheumatology (Oxford). 2004;43:
1045–9.
9. Gowa MA, Ibrahim MN, Memon BN, Raza SJ. A cross sectional study on
juvenile idiopathic arthritis in paediatric population. J Pak Med Assoc. 2015;
65:370–3.
10. Weiss PF, Klink AJ, Behrens EM, Sherry DD, Finkel TH, Feudtner C, et al.
Enthesitis in an inception cohort of enthesitis-related arthritis. Arthritis Care
Res. 2011;63:1307–12.
11. Dubois-Ferrière V, Belaieff W, Lascombes P, de Coulon G, Ceroni D. Transient
synovitis of the hip: which investigations are truly useful? Swiss Med Wkly.
2015;145:w14176.
12. Rostom S, Amine B, Bensabbah R, Abouqal R, Hajjaj-Hassouni N. Hip
involvement in juvenile idiopathic arthritis. Clin Rheumatol. 2008;27:791–4.
13. Foster HE, Eltringham MS, Kay LJ, Friswell M, Abinun M, Myers A. Delay in
access to appropriate care for children presenting with musculoskeletal
symptoms and ultimately diagnosed with juvenile idiopathic arthritis.
Arthritis Rheum. 2007;57:921–7.
14. Tzaribachev N, Benseler SM, Tyrrell PN, Meyer A, Kuemmerle-Deschner JB.
Predictors of delayed referral to a pediatric rheumatology center. Arthritis
Rheum. 2009;61:1367–72.
15. Singhal R, Perry DC, Khan FN, Cohen D, Stevenson HL, James LA, et al. The
use of CRP within a clinical prediction algorithm for the differentiation of
septic arthritis and transient synovitis in children. J Bone Joint Surg Br. 2011;
93:1556–61.
16. Horton DB, Scott FI, Haynes K, Putt ME, Rose CD, Lewis JD, et al. Antibiotic
exposure and juvenile idiopathic arthritis: a case–control study. Pediatrics.
2015;136:e333–43.
17. Arvonen M, Berntson L, Pokka T, Karttunen TJ, Vähäsalo P, Stoll ML. Gut
microbiota-host interactions and juvenile idiopathic arthritis. Pediatr
Rheumatol Online J. 2016;14:44.
18. Sen ES, Clarke SLN, Ramanan AV. The child with joint pain in primary care.
Best Pract Res Clin Rheumatol. 2014;28:888–906.
Aoust et al. Orphanet Journal of Rare Diseases  (2017) 12:43 Page 5 of 5
